Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Maja, Velkovski-Rouyer"'
Autor:
Ziad A. Massy, Jean Ferrières, Eric Bruckert, Céline Lange, Sophie Liabeuf, Maja Velkovski-Rouyer, Bénédicte Stengel, Carole Ayav, Christian Combe, Denis Fouque, Luc Frimat, Yves-Edouard Herpe, Maurice Laville, Ziad Massy, Karine Legrand, Marie Metzger, Elodie Speyer, Bruno Moulin, Gaétan Lebrun, Éric Magnant, Gabriel Choukroun, Jean Philippe Bourdenx, Marie Essig, Raymond Azar, Mustafa Smati, Mohamed Jamali, Alexandre Klein, Michel Delahousse, Séverine Martin, Eric Thervet, Xavier Belenfant, Pablo Urena, Carlos Vela, Dominique Chauveau, Viktor Panescu, François Glowacki, Maxime Hoffmann, Maryvonne Hourmant, Dominique Besnier, Angelo Testa, Philippe Zaoui, Charles Chazot, Laurent Juillard, Stéphane Burtey, Adrien Keller, Nassim Kamar
Publikováno v:
Kidney International Reports, Vol 4, Iss 11, Pp 1546-1554 (2019)
Introduction: We describe the characteristics of patients with moderate/advanced chronic kidney disease (CKD) according to receipt of lipid-lowering therapy (LLT), and whether they achieved low-density lipoprotein cholesterol (LDL-C) targets for high
Externí odkaz:
https://doaj.org/article/2e2d670b48f24d0da27d45f04c41f401
Autor:
Maja Velkovski-Rouyer, Jean Ferrières, Ziad A. Massy, Céline Lange, Sophie Liabeuf, Eric Bruckert, Bénédicte Stengel
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Maja Velkovski-Rouyer, Matthieu Wargny, Brice Leclère, E. Nobecourt, Emeric Scharbarg, Sophie de Visme, Matthieu Hanf, Michel Krempf, Patrick Plunian
Publikováno v:
Annales d'Endocrinologie
Annales d'Endocrinologie, Elsevier Masson, 2019, 80 (2), pp.136-137. ⟨10.1016/j.ando.2018.11.005⟩
Annales d'Endocrinologie, Elsevier Masson, 2019, 80 (2), pp.136-137. ⟨10.1016/j.ando.2018.11.005⟩
Annales d'Endocrinologie - In Press.Proof corrected by the author Available online since dimanche 3 mars 2019
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ee4a5be665e329a109acaa9d2c0a0d
https://hal.inrae.fr/hal-02624264
https://hal.inrae.fr/hal-02624264
Autor:
Fu-Tien Chiang, Dominik Lautsch, Ami Vyas, Jean Ferrières, Gaetano M. De Ferrari, Kian Keong Poh, Maja Velkovski-Rouyer, Philippe Brudi, Lori D. Bash, Anselm K. Gitt, Carl A. Baxter, Wael Almahmeed, Baishali M. Ambegaonkar, Martin Horack, Moses Elisaf
Publikováno v:
International journal of cardiology. 270
Guidelines recommend lifestyle modification and medications to control risk factors in coronary heart disease (CHD). Using data from the observational DYSIS II study, we sought to evaluate the use of guideline-recommended treatments at discharge for
Autor:
Ian, Graham, Chuck, Shear, Pieter, De Graeff, Caroline, Boulton, Alberico L, Catapano, Wendy Gattis, Stough, Stefan C, Carlsson, Guy, De Backer, Joseph, Emmerich, Scott, Greenfeder, Albert M, Kim, Dominik, Lautsch, Tu, Nguyen, Steven E, Nissen, Krishna, Prasad, Kausik K, Ray, Jennifer G, Robinson, William J, Sasiela, Karsten, Bruins Slot, Erik, Stroes, Tom, Thuren, Bart, Van der Schueren, Maja, Velkovski-Rouyer, Scott M, Wasserman, Olov, Wiklund, Emmanouil, Zouridakis, Cathrine, Thorstensen
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy, 4(2). Oxford University Press
The very high occurrence of cardiovascular events presents a major public health issue because treatment remains suboptimal. Lowering low-density lipoprotein cholesterol (LDL-C) with statins or ezetimibe in combination with a statin reduces major adv
Autor:
Veronica Ashton, Philippe Brudi, Maja Velkovski Rouyer, Jean Ferrières, Anselm K. Gitt, Baishali M. Ambegaonkar, Dominik Lautsch
Publikováno v:
Archives of cardiovascular diseases. 110(3)
European guidelines recommend a low-density lipoprotein cholesterol (LDL-C) target of1.8mmol/L (70mg/dL), and/or a≥50% reduction when the target level cannot be reached, for patients at very high cardiovascular risk, and high-potency lipid-lowering
Autor:
Maja Velkovski-Rouyer, Veronica Ashton, Dominik Lautsch, Jean Ferrières, Anselm K. Gitt, Baishali M. Ambegaonkar, Philippe Brudi
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 8(1)
Aim We sought to determine achievement of lipid targets according to current European guidelines (low-density lipoprotein cholesterol [LDL-C] ≤70mg/dL) in patients with stable coronary heart disease (CHD) with or without lipid-lowering therapy (LLT
Autor:
Dominik Lautsch, Anselm K. Gitt, Baishali M. Ambegaonkar, Maja Velkovski Rouyer, Jean Ferrières, Martin Horack, Philippe Brudi
Publikováno v:
International Journal of Cardiology. 222:793-794
Autor:
K. Keong Poh, Martin Horack, Philippe Brudi, G M De Ferrari, Lori D. Bash, W. Al Mahmeed, Anselm K. Gitt, Jean Ferrières, Baishali M. Ambegaonkar, Maja Velkovski-Rouyer, Ami Vyas, Dominik Lautsch, Carl A. Baxter, Fu-Tien Chiang
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 10:130
Background European guidelines recommend lifestyle modification and evidence-based drugs to control risk factors in coronary heart disease (CHD). Purpose To evaluate the use of guideline-recommended drugs at discharge for ACS or in the chronic phase
Autor:
Dominik Lautsch, Maja Velkovski-Rouyer, Veronica Ashton, Jean Ferrières, Philippe Brudi, Anselm K. Gitt, Baishali M. Ambegaonkar
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 8(1):16-17
AimTo document low-density lipoprotein cholesterol (LDL-C) values during hospitalization of ACS patients with/without lipid-lowering therapy (LLT) at admission, and achievement of the ESC LDL-C target (LDL-C≤70mg/dL) at 4 months following the acute